[1]
Xie, J.; Liang, R.; Wang, Y.; Huang, J.; Cao, X.; Niu, B. Progress in target drug molecules for Alzheimer’s disease. Curr. Top. Med. Chem., 2020, 20(1), 4-36.
[2]
Lv, W.; Wang, X.; Xu, Q.; Lu, W. Mechanisms and characteristics of sulfonylureas and glinides. Curr. Top. Med. Chem., 2020, 20(1), 37-56.
Current Topics in Medicinal Chemistry
Title:Advancement of Technology for Drug Discovery and Development – Part II
Volume: 20 Issue: 1
Author(s): Bing Niu
Affiliation:
Export Options
About this article
Cite this article as:
Niu Bing , Advancement of Technology for Drug Discovery and Development – Part II, Current Topics in Medicinal Chemistry 2020; 20 (1) . https://dx.doi.org/10.2174/156802662001200122123740
DOI https://dx.doi.org/10.2174/156802662001200122123740 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
31
6
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diversity-Oriented Synthetic Approaches for Furoindoline: A Review
Current Organic Synthesis Naturally-occurring Dimers of Flavonoids as Anticarcinogens
Anti-Cancer Agents in Medicinal Chemistry The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
Current Pediatric Reviews Resistant TB: Newer Drugs and Community Approach
Recent Patents on Anti-Infective Drug Discovery Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Functional Cell-Based Assays in Microliter Volumes for Ultra-High Throughput Screening
Combinatorial Chemistry & High Throughput Screening Exercise Induced Neuroplasticity to Enhance Therapeutic Outcomes of Cognitive Remediation in Schizophrenia: Analyzing the Role of Brai nderived Neurotrophic Factor
CNS & Neurological Disorders - Drug Targets QSAR and Docking Studies on Propenone Derivatives as Dual COX and 5- LOX Inhibitors
Letters in Organic Chemistry Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series
Current Alzheimer Research The Role of Osteopontin in Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
Inflammation & Allergy - Drug Targets (Discontinued) Impact of MCP -1 in Atherosclerosis
Current Pharmaceutical Design CYP2A5 Induction and Hepatocellular Stress: An Adaptive Response to Perturbations of Heme Homeostasis
Current Drug Metabolism In Vitro Solubility Assays in Drug Discovery
Current Drug Metabolism Influence of Lithium Treatment on GDNF Serum and CSF Concentrations in Patients with Early Alzheimers Disease
Current Alzheimer Research Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate
Current Medicinal Chemistry Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design The Role of Microglia in Antibody-Mediated Clearance of Amyloid-Beta from the Brain
CNS & Neurological Disorders - Drug Targets New Agents and Approaches to Treatment in Niemann-Pick Type C Disease
Current Pharmaceutical Biotechnology Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design Drug Likeness and Selective Functionalization of Quinoxalines
Current Organic Synthesis